DK3090068T3 - Fremgangsmåde og kit til ikke-invasiv detektering af egfr-genmutationer - Google Patents
Fremgangsmåde og kit til ikke-invasiv detektering af egfr-genmutationer Download PDFInfo
- Publication number
- DK3090068T3 DK3090068T3 DK14877282.5T DK14877282T DK3090068T3 DK 3090068 T3 DK3090068 T3 DK 3090068T3 DK 14877282 T DK14877282 T DK 14877282T DK 3090068 T3 DK3090068 T3 DK 3090068T3
- Authority
- DK
- Denmark
- Prior art keywords
- genutations
- egfr
- kit
- procedure
- invasive detection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310756037.2A CN104745679B (zh) | 2013-12-31 | 2013-12-31 | 一种无创检测egfr基因突变的方法及试剂盒 |
| PCT/CN2014/093940 WO2015101175A1 (en) | 2013-12-31 | 2014-12-16 | Method and kit for non-invasively detecting egfr gene mutaions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3090068T3 true DK3090068T3 (da) | 2019-08-26 |
Family
ID=53493183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14877282.5T DK3090068T3 (da) | 2013-12-31 | 2014-12-16 | Fremgangsmåde og kit til ikke-invasiv detektering af egfr-genmutationer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10648037B2 (da) |
| EP (1) | EP3090068B1 (da) |
| CN (1) | CN104745679B (da) |
| DK (1) | DK3090068T3 (da) |
| ES (1) | ES2742310T3 (da) |
| HK (1) | HK1209800A1 (da) |
| HU (1) | HUE046100T2 (da) |
| PL (1) | PL3090068T3 (da) |
| PT (1) | PT3090068T (da) |
| RS (1) | RS59156B1 (da) |
| WO (1) | WO2015101175A1 (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11286519B2 (en) | 2013-12-11 | 2022-03-29 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
| AU2014362227B2 (en) | 2013-12-11 | 2021-05-13 | Accuragen Holdings Limited | Compositions and methods for detecting rare sequence variants |
| US11859246B2 (en) | 2013-12-11 | 2024-01-02 | Accuragen Holdings Limited | Methods and compositions for enrichment of amplification products |
| JP7008016B2 (ja) | 2015-10-09 | 2022-01-25 | アキュラジェン ホールディングス リミテッド | 増幅産生物の富化のための方法および組成物 |
| CA3005101A1 (en) * | 2015-11-16 | 2017-05-26 | Progenity, Inc. | Nucleic acids and methods for detecting methylation status |
| CN105986030A (zh) * | 2016-02-03 | 2016-10-05 | 广州市基准医疗有限责任公司 | 甲基化dna检测方法 |
| WO2017201102A1 (en) | 2016-05-16 | 2017-11-23 | Accuragen Holdings Limited | Method of improved sequencing by strand identification |
| KR101915701B1 (ko) * | 2016-06-16 | 2018-11-07 | 한국한의학연구원 | 돌연변이 발생률의 측정 방법 |
| CN107630075A (zh) * | 2016-07-18 | 2018-01-26 | 丰技生物科技股份有限公司 | Egfr基因的突变位点的检测方法 |
| CN106399518B (zh) * | 2016-09-30 | 2019-11-22 | 广州易活生物科技有限公司 | 用于人egfr基因突变检测的探针、试剂盒及其检测方法 |
| CA3033749A1 (en) | 2016-08-15 | 2018-02-22 | Accuragen Holdings Limited | Compositions and methods for detecting rare sequence variants |
| CN106544341A (zh) * | 2017-01-17 | 2017-03-29 | 上海亿康医学检验所有限公司 | 高效检测样本中的ctDNA的方法 |
| CN106929582A (zh) * | 2017-03-21 | 2017-07-07 | 杭州联川基因诊断技术有限公司 | 一种检测egfr基因突变的方法及试剂盒 |
| CN107365867A (zh) * | 2017-09-04 | 2017-11-21 | 天津华大医学检验所有限公司 | 一种用于检测基因组目标区域的引物组合物及其应用 |
| US11203782B2 (en) | 2018-03-29 | 2021-12-21 | Accuragen Holdings Limited | Compositions and methods comprising asymmetric barcoding |
| CN112080558B (zh) * | 2019-06-13 | 2024-03-12 | 杭州贝瑞和康基因诊断技术有限公司 | 同时检测hba1/2和hbb基因突变的试剂盒和方法 |
| CN110349629B (zh) * | 2019-06-20 | 2021-08-06 | 湖南赛哲医学检验所有限公司 | 一种利用宏基因组或宏转录组检测微生物的分析方法 |
| CN111518901A (zh) * | 2020-04-30 | 2020-08-11 | 北京和合医学诊断技术股份有限公司 | 用于检测egfr基因突变的引物组及其应用方法 |
| US20220025460A1 (en) * | 2020-07-21 | 2022-01-27 | The University Of Tokyo | Method and kit for determining neuromuscular disease in subject |
| CN112501279A (zh) * | 2020-12-18 | 2021-03-16 | 长沙艾迪康医学检验实验室有限公司 | 检测piezo1基因突变的引物、试剂盒和方法 |
| CN114350657B (zh) * | 2022-01-26 | 2023-07-18 | 复旦大学附属金山医院(上海市金山区眼病防治所、上海市金山区核化伤害应急救治中心) | 一种促进环状rna生成的反向互补短侧翼序列及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6312913B1 (en) * | 2000-07-21 | 2001-11-06 | Incyte Genomics, Inc. | Method for isolating and characterizing nucleic acid sequences |
| CN102203287B (zh) * | 2008-08-26 | 2017-09-19 | 弗卢迪格姆公司 | 增加样本和/或靶通量的测定方法 |
| US9334529B2 (en) * | 2009-11-03 | 2016-05-10 | Leijon Diagnostics Ab | Genotyping of N loci in a target nucleic acid molecule |
| CN101921830B (zh) * | 2010-03-29 | 2013-03-27 | 苏州工业园区为真生物医药科技有限公司 | Egfr基因突变的快速检测 |
| CN101967684B (zh) * | 2010-09-01 | 2013-02-27 | 深圳华大基因科技有限公司 | 一种测序文库及其制备方法、一种末端测序方法和装置 |
| JP6153874B2 (ja) * | 2011-02-09 | 2017-06-28 | ナテラ， インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
| CN102181533B (zh) * | 2011-03-17 | 2015-04-01 | 北京贝瑞和康生物技术有限公司 | 多样本混合测序方法及试剂盒 |
| CN102373287B (zh) * | 2011-11-30 | 2013-05-15 | 盛司潼 | 一种检测肺癌易感基因的方法及试剂盒 |
| CN102373288B (zh) * | 2011-11-30 | 2013-12-11 | 盛司潼 | 一种对目标区域进行测序的方法及试剂盒 |
| CN102586422B (zh) * | 2011-12-27 | 2015-01-07 | 盛司潼 | 一种对6磷酸葡萄糖脱氢酶基因进行测序的方法及试剂盒 |
| CN103298955B (zh) | 2012-01-10 | 2016-06-08 | 北京贝瑞和康生物技术股份有限公司 | 用于构建血浆dna测序文库的方法和试剂盒 |
| WO2013138510A1 (en) | 2012-03-13 | 2013-09-19 | Patel Abhijit Ajit | Measurement of nucleic acid variants using highly-multiplexed error-suppressed deep sequencing |
| US9133490B2 (en) * | 2012-05-16 | 2015-09-15 | Transgenomic, Inc. | Step-up method for COLD-PCR enrichment |
| CN102851375B (zh) * | 2012-09-11 | 2014-02-19 | 上海源奇生物医药科技有限公司 | 检测egfr基因突变的引物、探针及其试剂盒和使用方法 |
| GB201223025D0 (en) * | 2012-12-20 | 2013-02-06 | Medizinische Universitaet Graz | Prediction of the treatment response to an anti-EGFR molecule in colorectal cancer patients |
-
2013
- 2013-12-31 CN CN201310756037.2A patent/CN104745679B/zh active Active
-
2014
- 2014-12-16 DK DK14877282.5T patent/DK3090068T3/da active
- 2014-12-16 PT PT14877282T patent/PT3090068T/pt unknown
- 2014-12-16 PL PL14877282T patent/PL3090068T3/pl unknown
- 2014-12-16 EP EP14877282.5A patent/EP3090068B1/en active Active
- 2014-12-16 RS RSP20191066 patent/RS59156B1/sr unknown
- 2014-12-16 ES ES14877282T patent/ES2742310T3/es active Active
- 2014-12-16 WO PCT/CN2014/093940 patent/WO2015101175A1/en active Application Filing
- 2014-12-16 HU HUE14877282A patent/HUE046100T2/hu unknown
- 2014-12-16 US US15/109,308 patent/US10648037B2/en active Active
-
2015
- 2015-10-28 HK HK15110654.9A patent/HK1209800A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3090068B1 (en) | 2019-05-29 |
| WO2015101175A1 (en) | 2015-07-09 |
| HK1209800A1 (en) | 2016-04-08 |
| PT3090068T (pt) | 2019-09-10 |
| EP3090068A1 (en) | 2016-11-09 |
| EP3090068A4 (en) | 2017-07-05 |
| HUE046100T2 (hu) | 2020-01-28 |
| ES2742310T3 (es) | 2020-02-13 |
| PL3090068T3 (pl) | 2019-11-29 |
| US20170009302A1 (en) | 2017-01-12 |
| CN104745679B (zh) | 2018-06-15 |
| US10648037B2 (en) | 2020-05-12 |
| CN104745679A (zh) | 2015-07-01 |
| RS59156B1 (sr) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3090068T3 (da) | Fremgangsmåde og kit til ikke-invasiv detektering af egfr-genmutationer | |
| DK3087095T3 (da) | FcRn-antagonist og fremgangsmåder til anvendelse | |
| DK3317284T3 (da) | Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse | |
| DK3653221T3 (da) | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder | |
| DK3178849T3 (da) | Kombination af anti-lag-3-antistoffer og anti-pd-1-antistoffer til behandling af tumorer | |
| DK3205650T3 (da) | Egfr-hæmmer og fremstilling og anvendelse deraf | |
| DK3215532T3 (da) | Anti-TIM3-antistoffer og fremgangsmåder til anvendelse | |
| DK3019200T3 (da) | Oligonukleotid-ligand-konjugater og fremgangsmåde til fremstiling deraf | |
| DK3055803T3 (da) | Sporing og analyse af kliniske resultater | |
| DK3083689T3 (da) | Anti-CD3-antistoffer og fremgangsmåder til anvendelse | |
| DK3035926T3 (da) | Forbindelser og fremgangsmåder til behandling af en epilepsilidelse | |
| DK2961831T3 (da) | Sammensætninger og fremgangsmåder til immunterapi | |
| DK3086807T3 (da) | Antistoffer og fremgangsmåder til anvendelse | |
| DK3009021T3 (da) | Handske og fremgangsmåde til fremstilling deraf | |
| DK3050883T3 (da) | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter | |
| DK3363805T3 (da) | Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner | |
| DK3122358T3 (da) | Kombinationer af fgfr- og cmet-hæmmere til cancerbehandling | |
| DK3079719T3 (da) | ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK2892912T3 (da) | C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf | |
| DK3071215T3 (da) | Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension | |
| DK3076972T3 (da) | Cancerbehandling med kombination af plinabulin og taxan | |
| DK3067355T3 (da) | Krystaller af diazabicyclooctanderivat og fremgangsmåde til fremstilling af krystaller af diazabicyclooctanderivat | |
| DK3082902T3 (da) | Kropsbåret injektor og anvendelsesmetode | |
| DK2981541T3 (da) | Syntese og anvendelse af isotopmærkede glycaner | |
| DK3540429T3 (da) | Indretning og fremgangsmåder til anvendelse af indretning til detektion af hyperammoniæmi |